Navigation Links
Kinetics Foundation and National Parkinson Foundation (NPF) Announce their Partnership to Evaluate Objective Parkinson's Disease Measurement System

MIAMI, June 23, 2011 /PRNewswire-USNewswire/ -- The National Parkinson Foundation (NPF) and the Kinetics Foundation are pleased to announce their partnership to evaluate Kinetic's Objective Parkinson's Disease Measurement (OPDM) system as a tool for more accurately measuring the symptoms of Parkinson's disease (PD).  The evaluation will take place at six NPF Centers of Excellence enrolled in NPF's groundbreaking Quality Improvement Initiative (QII).

"It is our hope that our OPDM system can help more accurately measure the results of treatments than the rating scales the medical community has been commonly using up until today," said Ken Kubota, program director of the Kinetics Foundation.

NPF will integrate the OPDM system into QII, the largest prospective study of PD in history with over 4,000 patients enrolled at 19 centers in four countries. The study aims to reveal current patterns in clinical practice, drive quality improvement in PD care and spawn comparative effectiveness research.  Data collection covers key areas necessary to identify and improve care quality such as comorbidities, medications and exercise. The evaluation is expected to be completed in early 2012.

"We are thrilled to have this opportunity to evaluate these devices," said Peter N. Schmidt, PhD, NPF's VP of programs and CIO. "We hope that the rich information provided by the sensors will give additional insight into the motor symptoms of PD and help us to understand the benefits of different clinical approaches."

The OPDM system is comprised of both dexterity and mobility measurement devices, which communicate to a central server via the Internet. Researchers access the data on this central server through a web interface. The OPDM system is likely to emerge as the first to measure PD patient symptoms objectively, rather than subjectively. The OPDM system consists of two devices that measure dexterity, using keyboard and peg-board tests, and mobility, tracking arm, leg and torso movement as the person being tested rises from a chair, walks across a room and returns.

"The Quality Improvement Initiative is the first program of its kind to systematically evaluate the current standard of care," commented James McNames, Professor and Chair of Electrical & Computer Engineering at Portland State University and Chief Executive Officer of APDM, Inc., who is not affiliated with the study. "This is a great opportunity to help clinicians and patients improve the effectiveness of their therapy and quality of life."

NPF's Quality Improvement Initiative is a consortium of leading experts in PD working together to identify best practices by systematically tracking their patients' therapies and outcomes over time. QII aims to create and share models of excellent care so that every Parkinson's patient receives the most effective treatment options available, whether they are seen by a specialist at an NPF Center of Excellence, a general neurologist or their primary care physician.

About Parkinson's disease
Parkinson's disease is the second most common neurodegenerative disease after Alzheimer's with an estimated one million people with the disease in the United States and four to six million worldwide. At present, there is no cure for Parkinson's disease and 50-60,000 new cases are diagnosed each year in the United States.

About the National Parkinson Foundation
The National Parkinson Foundation supports a strong network of 43 centers of excellence dedicated to excellence in research and providing comprehensive, interdisciplinary care to more than 50,000 Parkinson's patients and their families worldwide. Founded in 1957, the National Parkinson Foundation's mission is to improve the quality of care for people with Parkinson's disease through research, education, and outreach. Since 1982, NPF has funded more than $155 million in care, research and support services.

About the Kinetics Foundation
The Kinetics Foundation is a philanthropic foundation endeavoring to accelerate treatments and cures for Parkinson's disease focusing on: brain infusion techniques for neurotropic factors and the Objective Parkinson's Disease Measurement (OPDM) system.  OPDM is comprised of both dexterity and mobility measurement devices and a centralized server. For more information, visit

For more information about Parkinson's disease or the National Parkinson Foundation, please visit or call 1-800-4PD-INFO (473-4636).

SOURCE National Parkinson Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Neuro Kinetics Releases Updated Version of Neuro-Otologic Control and Analysis Software
2. MAP Pharmaceuticals to Present Data From LEVADEX® Pharmacokinetics and Pharmacodynamics Safety Studies at the 63rd Annual Meeting of the American Academy of Neurology
3. New Model Provides Insights Into Intravenous and Subcutaneous Immunoglobulin Pharmacokinetics in Patients With Primary Immunodeficiencies
4. Neuro Kinetics to Showcase I-Portal® Research at Brain Injury Awareness Day on Capitol Hill
5. Neuro Kinetics Presenting New Balance & Dizziness Research at American Balance Society Conference
6. Neuro Kinetics Named Manufacturer of the Year
7. Chimerixs Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics, Safety and Tolerability
8. Neuro Kinetics Receives HHS Therapeutic Discovery Grant to Further Research Into Early Diagnosis of Sports Concussions
9. Newly Revised Concepts in Clinical Pharmacokinetics Web-Based Continuing Education Course Offered by the University of Georgia
10. Neuro Kinetics to Showcase Enhanced Control & Analysis Software at Otolaryngology Conference
11. PharmaPendium(TM) Launches Pharmacokinetics Module
Post Your Comments:
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):